NCT02059681View on ClinicalTrials.gov

Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Chronic Myocardial Ischemia
Interventions
OTHER

Autologous bone marrow derived-CD133+ cells

Cell therapy

Trial Locations (3)

10126

Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino

20138

Centro Cardiologico Monzino, IRCCS, Milan

20900

Azienda Ospedaliera San Gerardo di Monza, Monza

All Listed Sponsors
collaborator

A.O.U. Città della Salute e della Scienza

OTHER

collaborator

Azienda Ospedaliera San Gerardo di Monza

OTHER

lead

Centro Cardiologico Monzino

OTHER

NCT02059681 - Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial) | Biotech Hunter | Biotech Hunter